This optional unaccredited session is offered in cooperation with our partner Searchlight Pharma.

New Estetrol-containing COC offers benefits to patient 

12:00pm - 12:40pm

Objectives:

At the end of this session, participants will be able to:

• Review the unique benefits of estetrol (E4) and how it differs from ethinyl estradiol (EE)
• Demonstrate how the unique features of Nextstellis can provide women with the ideal COC that offers contraceptive efficacy, a low rate of side effects, favourable safety, and a predictable bleeding pattern

Speaker:

Dr. Amanda Black MD MPH FRCSC 

Dr. Amanda Black is a Professor of Obstetrics and Gynecology at the University of Ottawa. She is an Associate Scientist at The Ottawa Hospital Research Institute and holds the Dr. Elaine Jolly Chair in Women’s Health Research.  She is the current President of the Society of Obstetricians and Gynecologists of Canada. 

She completed medical training at the University of Western Ontario, University of Ottawa, and Queen’s University and holds a Master of Public Health from Johns Hopkins University. She is recognized as a national and international expert in women's health, with over 400 invited presentations and over 200 publications. She has worked on and developed numerous women's health initiatives during her career, including the National Contraception Awareness Program, the National Compassionate Contraception Program, website and app development, and national and international guidelines.  She has provided expertise to Health Canada, Stats Canada, the Centers for Disease Control, and the World Health Organization.

She continues to work “in the trenches” as a General Obstetrician/Gynecologist with a special interest in Family Planning.